Stem Cell Derived Organoids Fill Gap in Modeling Common Ailments
Scientists used human pluripotent stem cells to generate human embryonic colons in a laboratory that function much like natural human tissues when transplanted into mice, according to research published June 22 in Cell Stem Cell.
The study is believed to be the first time human colon organoids have been successfully tissue engineered in this manner, according to researchers at Cincinnati Children’s Hospital Medical Center who led the project.
The technology allows diseases of the colon to be studied in unprecedented detail in a human modeling system. It also comes with the potential to one day generate human gastrointestinal (GI) tract tissues for transplant into patients, according to James Wells, PhD, senior study investigator and director of the Cincinnati Children’s Pluripotent Stem Cell Center.
“Diseases affecting this region of the GI tract are quite prevalent and include ailments like colitis, colon cancer, Irritable Bowel Syndrome, Hirschsprung’s disease and polyposis syndromes,” Wells said. “We’ve been limited in how we can study these diseases, including the fact that animal models like mice don’t precisely recreate human disease processes in the gastrointestinal tract. This system allows us to very effectively model human diseases and human development.”
Building the GI Tract
In a series of studies published since 2009, researchers in Wells’ laboratory used human pluripotent stem cells (hPSCs) to grow embryonic-stage small intestines with a functioning nervous system, and the antrum and fundus regions of the human stomach.
The researchers – including Jorge Munera, PhD, first author and postdoctoral fellow in the Wells laboratory – note in their current paper the colon has been more difficult to generate than other parts of the GI tract.
Part of the challenge to identifying the correct genetic and molecular programming to coax hPSCs in to colonic organoids has been a lack of data about embryonic development of the organ, according to the authors. They addressed this by conducting a series of molecular and genetic screens of developing hindgut tissues in animal models. The hindgut is the portion of the developing gut that gives rise to the entire large intestine – which includes the cecum, colon and rectum.
They also mined public databases (GNCPro, TiGER, Human Protein Atlas) to identify molecular markers of the hindgut in the adult colon.
Frogs and Mice at Forefront
To develop a model for generating the human colon, scientists first identified SATB2 (special AT-rich sequence-binding protein 2) as a definitive molecular marker for hindgut in frogs, mice and in humans.
SATB2 is a DNA-binding protein that facilitates structural organization of chromosomes in the nucleus of cells.
The protein sequence of SATB2 is remarkably similar between frogs, mice and humans. This led the authors to the hypothesis that molecular signals regulating SATB2 in frogs and mice could be used to make human colon organoids that express the protein.
The authors also noticed that signaling from the growth factor BMP (bone morphogenetic protein) was highly active in the SATB2-expressing region of the gut tube. The researchers learned during their analysis of frog, mouse and human stem-cell derived intestine that signaling by BMP is needed to establish SATB2 in the developing hindgut. With SABT2 as a marker, the researchers show BMP signaling is required for development of tissues specific to the posterior gut region of frogs and mice where the colon develops.
When BMP protein was added for three days in human pluripotent stem cell-derived gut tube cultures, it induced a posterior HOX code. HOX includes a critical set of genes that help control the embryo’s development plan from head to toe. Researchers report the posterior HOX helps control the formation of SATB2-expressing human colon organoids.
Testing Translational Potential
To see how human GI tissues perform in a living organism – and to test their future therapeutic potential – the research team included collaborators from the Division of Surgery, led by Michael Helmrath, MD, a pediatric surgeon and director of the Surgical Research program.
The tissue-engineered colonic organoids were transplanted into the kidney capsules of immunocompromised mice for six to 10 weeks. During observation and analysis of the now in vivo organoids, study authors looked for signs of posterior region enteroendocrine cells, which make hormones found in naturally developed human colon.
Researchers report that following transplant, the human colonic organoids assumed the form, different structures and molecular and cell properties of the human colon.
Munera, study first author, pointed to a number of new ways that human colon organoids could be used study disease.
“By exposing human colonic organoids to inflammatory triggers, we can now learn how the cell lining of the colon and the supporting cells beneath cooperate to respond to inflammation,” Munera said. “This could be very relevant for patients with Crohn’s disease or ulcerative colitis. And because the microbiome, the organisms that live in our guts, are most concentrated in the colon, the organoids potentially could be used to model the human microbiome in health and disease.”
Like other parts of the GI tract grown by the researchers, the human colon organoids also create a potential new platform for testing new drugs before the start of clinical trials. Most oral drugs are absorbed by the body through the gut.
The Latest on: organoids
Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference
on April 18, 2018 at 8:30 am
ELX-02 is an investigational, novel translational read-through inducing drug designed to restore synthesis of full-length functional proteins Late Breaker evaluation of ELX-02 in cystic fibrosis patient organoids with nonsense mutations Eloxx expects to ... […]
Mini-Brains Just Grew Their Own Blood Vessels—Here’s Why That’s Great News
on April 18, 2018 at 8:00 am
When grown inside a host mouse (creepy!), brain balls—or as the academic community calls them, cerebral organoids—organize into 3D structures remarkably similar to the developing brain. They sparkle with electrical activity. They develop retinal cells ... […]
Mini Human Brains Grow in Mice Skulls: What Does This Mean?
on April 18, 2018 at 7:23 am
Scientists at the Salk Institute are responsible for the successful implantation of human cerebral organoids into the brains of another species, reports STAT News. The host brain even managed to supply the lentil-sized mini cerebrums with enough blood and ... […]
Human Brain Organoids Thrive in Mouse Brains
on April 17, 2018 at 7:49 am
Brain organoids, stem-cell-based models of real brain tissue, have moved into petri dishes and test tubes, but they have never quite felt themselves at home. The organoids’ cells don’t divide or diversify very much, and they don’t live very long ... […]
Miniature human brain implants survive, grow inside mice for months
on April 16, 2018 at 12:37 pm
April 16 (UPI) --Miniature human brains, or human brain organoids, can survive and grow after being implanted in the skulls of mice. It's the first time human cerebral organoids have been installed inside another species. Researchers describe the ... […]
Miniature human brains grow for months when implanted in mice skulls
on April 16, 2018 at 8:16 am
It’s “an important technical advance,” said neuroscientist Michal Stachowiak of the State University of New York, Buffalo, who created human cerebral organoids to study schizophrenia, and “an important initial step toward using organoids in ... […]
Patient-Derived Organoids Predict Cancer Treatment Response
on April 10, 2018 at 8:18 am
In a first-of-its-kind trial, researchers used tiny, simplified organs grown from patients’ cancer cells—so-called patient-derived organoids (PDOs)—to compare responses to anticancer agents in the laboratory and the clinic. The researchers focused on ... […]
Organoids created from patients' bladder cancers could guide treatment
on April 7, 2018 at 5:26 pm
Researchers have created patient-specific bladder cancer organoids that mimic many of the characteristics of actual tumors. The use of organoids, tiny 3-D spheres derived from a patient's own tumor, may be useful in the future to guide treatment of patients. […]
Organoids from bladder cancer could help doctors treat disease
on April 6, 2018 at 8:33 am
April 6 (UPI) --Organoids derived from a patient's bladder cancer cells hold promise for future treatment of the disease, according to researchers in a new study. Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian created the ... […]
Organoids created from patients' bladder cancers could guide treatment
on April 5, 2018 at 10:10 am
Organoids created from the bladder cancers of patients mimic the characteristics of each patient's tumor and may be used in the future to identify the best treatment for each patient. Credit: Columbia University Irving Medical Center Columbia University ... […]
via Google News and Bing News